JESSICA PECHO: Open Payments
NPI 1528627239 · NEW LENOX, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 12 payments from 9 companies in 2025. Trend: 2023 $87 · 2024 $162 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| TerSera Therapeutics LLC | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Immunocore Limited | 1 | $17 |
Products named: REBLOZYL, SCEMBLIX, NINLARO, Zoladex, KISQALI, KEYTRUDA, ICLUSIG, Trodelvy.
Industry payments across IL — which companies pay providers there.
